← back to search

Christopher A. Miller

University of Manchester · GB
Area of research
Cancer Research · Hematology
Research interest
Research interests include Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research, Genetic factors in colorectal cancer, and Lymphoma Diagnosis and Treatment.
h-index
96
citations
80,620
works
551
NIH funding
primary concept
Medicine
email

Recent publications

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival
Communications Biology 2023cited by 31position: middledoi
Clonal Hematopoiesis and Risk of Incident Lung Cancer
Journal of Clinical Oncology 2022cited by 80position: middledoi
Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence
Journal of Molecular Diagnostics 2022cited by 42position: firstdoi
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Cell 2020cited by 527position: middledoi
Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons
Brain 2020cited by 91position: middledoi
The prognostic effects of somatic mutations in ER-positive breast cancer
Nature Communications 2018cited by 140position: middledoi
Somatic mutations and clonal hematopoiesis in congenital neutropenia
Blood 2017cited by 121position: middledoi
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
New England Journal of Medicine 2016cited by 783position: middledoi
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline <i>POLE</i> Deficiency Treated with Checkpoint Blockade Immunotherapy
Cancer Discovery 2016cited by 294position: middledoi
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Blood 2015cited by 237position: middledoi
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Nature Medicine 2014cited by 1,877position: middledoi
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Nature 2014cited by 877position: middledoi
Mutational landscape and significance across 12 major cancer types
Nature 2013cited by 4,487position: middledoi
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Cell Reports 2013cited by 622position: middledoi
[2+2+2] Cycloadditions of Siloxy Alkynes with 1,2‐Diazines: From Reaction Discovery to Identification of an Antiglycolytic Chemotype
Angewandte Chemie International Edition 2013cited by 28position: middledoi
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Nature 2012cited by 2,005position: middledoi
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
Cell 2012cited by 1,564position: middledoi
Whole-genome analysis informs breast cancer response to aromatase inhibition
Nature 2012cited by 1,031position: middledoi
Assembly of Four Diverse Heterocyclic Libraries Enabled by Prins Cyclization, Au-Catalyzed Enyne Cycloisomerization, and Automated Amide Synthesis
The Journal of Organic Chemistry 2012cited by 27position: middledoi

Grants

Model Theory of Valued Differential Fields
NSF2154086$51,3702022–2028PIRePORTER
Dissertation Research: Intra-population genomic and metabolic diversity among understudied archaea in methane-cycling wetlands
NSF1701970$20,2152017–2018PIRePORTER
Travel Grant Support for IEEE ICCCN 2013 Conference
NSF1341327$12,0002013–2015PIRePORTER
Tameness in expansions of the real field
NSF1001176$172,0292010–2014PIRePORTER
U.S. participation in "O-minimal Structures and Real Analytic Geometry"
NSF0753096$40,0002008–2009PIRePORTER
Real analytic geometry and model theory
NSF9988855$78,2462000–2004PIRePORTER
Mathematical Sciences: Real Analytic Geometry and Model Theory
NSF9704594$67,8091997–2000PIRePORTER
Mathematical Sciences: Real Analytic Geometry and Model Theory
NSF9896225$51,1471997–2000PIRePORTER
Protein Stabilization and Destabilization by Guanidine Salts
NSF9417773$235,0001995–1999PIRePORTER
Mathematical Sciences: Postdoctoral Research Fellowship
NSF9407549$75,0001994–1998PIRePORTER
International Postdoctoral Fellows: Mechanisms Controlling Miniemulsion Polymerization
NSF9401958$19,3001994–1995PIRePORTER
Purchase Research Equipment
NSF7919864$21,5001979–1981PIRePORTER
Reconstitution of Nerve Excitatory Systems in Artificial Planar Bilayer Membranes
NSF7623212$44,0001977–1979PIRePORTER

Frequent collaborators

Matthew J. Walter · École de management de Lyon5 papers (2013–2022)Daniel C. Link · Palmetto Hematology Oncology4 papers (2014–2022)Elaine R. Mardis · James S. McDonnell Foundation4 papers (2014–2023)Timothy J. Ley · University of Missouri–St. Louis4 papers (2013–2022)Li Ding · South China Institute of Collaborative Innovation4 papers (2013–2022)Richard K. Wilson · Nationwide Children's Hospital3 papers (2013–2014)Robert S. Fulton · Case Western Reserve University3 papers (2014–2022)John S. Welch · Washington University in St. Louis3 papers (2013–2014)Mingchao Xie · AstraZeneca (United States)2 papers (2013–2014)Jack Baty · Research Institute of Radiology2 papers (2014–2017)Michael C. Wendl · Centre for Genomic Regulation2 papers (2013–2014)John F. DiPersio · Bluebird Bio (United States)2 papers (2014–2014)Sergey A. Kozmin · University of Chicago2 papers (2012–2013)Charles Lu · AbbVie (United States)2 papers (2013–2014)Joshua F. McMichael · James S. McDonnell Foundation2 papers (2013–2014)Michael D. McLellan · James S. McDonnell Foundation2 papers (2013–2014)E. Martina Bebin · University of Alabama at Birmingham1 papers (2020–2020) · 1 papers (2022–2022)Christopher Thomas · Technical University of Munich1 papers (2012–2012)Yukun Yuan · University of Michigan–Ann Arbor1 papers (2020–2020)